All Articles

Next-generation sequencing at initial workup of the patient with advanced non–small-cell lung cancer can shorten time between diagnosis and treatment and may improve survival.

Recent study found that the use of sotorasib after anti–PD-L1 therapy in patients with NSCLC increased the chance of severe adverse events and liver toxicity.

Patients with non–small-cell lung cancer with a history of prior radiotherapy before immune checkpoint inhibitor treatment are at increased risk for developing severe pneumonitis.

At JONS, we value the art of practicing medicine. We also value Art as Medicine to lift the human spirit. To honor these values, we have established an Artist in Residency program to showcase the works of art by artists touched by cancer.

The Navigating Iron Deficiency Anemia: My IV Iron Treatment Guide patient resource aims to empower patients and/or caregivers to actively engage in the discussion of iron deficiency anemia (IDA) and the intravenous (IV) iron treatment decision-making process.

The CATCH for September 2022 is awarded to Stephanie Hoopes, BSN, RN, OCN, ONN-CG, a survivorship nurse navigator at Prisma Health Cancer Institute in Greenville, SC.

In the United States, the second most commonly diagnosed cancer in both men and women is lung cancer, including both non–small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC).

Chronic lymphocytic leukemia (CLL) is the most common adult leukemia. The American Cancer Society estimates over 20,000 new CLL cases and over 4000 attributed deaths in 2022.

The Hopemore spa offers specialty spa services to cancer survivors, but it is also just like any other luxury spa. This unique dual-focus design allows it to provide an inviting and relaxing spa atmosphere to all their clients while at the same time providing discreet services to patients with cancer, according to Jeanna Doyle, spa owner, and Kris Astroff, director of skincare at The Hopemore spa.

Oral oncolytic drugs have a multitude of benefits for patients, including ease of use, improved quality of life, fewer clinic visits, and no need for IV therapy.